Universitätsklinikum Köln
60
5
8
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
6 terminated/withdrawn out of 60 trials
79.3%
-7.3% vs industry average
3%
2 trials in Phase 3/4
13%
3 of 23 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (60)
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic Cholangiocarcinoma
Role: collaborator
Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons
Role: collaborator
Children of Mentally Ill Parents-Network - CHIMPS-NET
Role: collaborator
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
Role: collaborator
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma
Role: collaborator
Boost Brittle Bones Before Birth
Role: collaborator
Immune-Marker Platform for Patients With Advanced Lung Cancer
Role: collaborator
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
Role: collaborator
S-ICD Implantation: US Based Pilot Study
Role: lead
Cognitive Screening of Patients with Hearing Loss
Role: collaborator
Investigation of the Audible ICD Alert Tone
Role: lead
Covid-19 Antibody Responses in Cystic Fibrosis
Role: lead
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
Role: collaborator
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
Role: collaborator
Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants
Role: lead
S-ICD Electrode Registry
Role: lead
Ventricular Tachycardia Ablation in LVAD Patients
Role: lead
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
Role: collaborator
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
Role: lead
Health Care Analysis on Myocardial Revascularization in Patients With Chronic Coronary Heart Disease (CHD)
Role: collaborator